Discover 2,402 paid clinical trials in Baltimore, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Clinical trial opportunities in Baltimore focus on areas such as oncology, dermatological conditions, neurological diseases, and gastrointestinal diseases like irritable bowel syndrome (IBS). The city’s research institutions are recruiting healthy volunteers looking for paid research opportunities or need clinical trials for a specific health condition, offering access to innovative treatments and therapies.
Filter
2
Filter results
Results: 2,402
Active & Responsive
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
for
Primary Sclerosing Cholangitis (PSC)
1 location in Baltimore
Sponsor: LISCure Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06699121
Phase2, Recruiting
Active & Responsive
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
for
Colorectal Cancer
1 location in Baltimore
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT06562543
Recruiting
Active & Responsive
Ocular Blood Flow Imaging for Glaucoma Assessment
for
Glaucoma
1 location in Baltimore
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT05726058
Recruiting
Active & Responsive
Retinal Blood Flow and Autoregulation
for
Glaucoma
3 locations in Baltimore
Sponsor: University of Maryland, Baltimore
Sex: All
Age: 18 - 70+
Code: NCT05344274
Recruiting
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
for
NASH - Nonalcoholic Steatohepatitis,
1 location in Baltimore
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06528314
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
for
NASH With Fibrosis, MASH With Fibrosis
1 location in Baltimore
Sponsor: Akero Therapeutics, Inc
Sex: All
Age: 18 - 70+
Code: NCT06215716
Phase3, Recruiting
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
1 location in Baltimore
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase2, Phase3, Recruiting
Active & Responsive
Asymptomatic Carotid Stenosis and Mobility Function With Exercise Intervention
Efficacy & Safety of Olvimulogene Nanivacirepvec & Platinum-doublet + Physician's Choice of Immune Checkpoint Inhibitor Compared to Docetaxel in NSCL Cancer
for
Advanced Non-squamous Non-small-cell Lung Cancer,
1 location in Baltimore
Sponsor: Genelux Corporation
Sex: All
Age: 18+
Code: NCT06463665
Phase2, Recruiting
Active & Responsive
Durvalumab and Tremelimumab in Combination With Chemotherapy in HIV-infected Patients With Non-small Cell Lung Cancer